Navigation Links
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
Date:12/11/2007

PRINCETON, N.J. and FOSTER CITY, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement to commercialize ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe for the treatment of virologically suppressed adults with HIV-1 infection, subject to the product's approval by the European Commission. If approved, ATRIPLA would represent the first and only once-daily single tablet regimen for HIV-1 infection in the European Union. The companies expect the European Commission to issue its decision by the end of the year.

Under this agreement, Bristol-Myers Squibb and Gilead share responsibility for commercializing ATRIPLA throughout the European Union and certain other European countries. Gilead will record revenues from future net sales of ATRIPLA in most of the European countries, while Bristol-Myers Squibb will record revenues in most of the European countries at percentages relative to the contribution represented by its individual product.

Bristol-Myers Squibb recently concluded an agreement with Merck & Co., Inc. under which Merck granted Bristol-Myers Squibb rights to co-commercialize ATRIPLA with Gilead in all of the European Union and certain other European countries. Previously, Merck had the exclusive right to market any product containing efavirenz (a component of ATRIPLA) in all European countries other than the United Kingdom, Germany, France, Italy, Spain and
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
2. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
3. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
4. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... England , April 17, 2015 ... genomics company announced today that their presence at the 2015 ... include a presentation by co-founder Nitzan Rosenfeld and ... also attending April 18 th - 22 nd . ... in plasma using ctDNA , forms part of ...
(Date:4/17/2015)... 17, 2015 ASSESS shows   ... is a viable alternative to tumour biopsy   ... patients with advanced NSCLC   AstraZeneca today presented ... circulating tumour DNA (ctDNA) testing for epidermal growth factor receptor ... cell lung cancer (NSCLC) in clinical practice. [ 1 ...
(Date:4/17/2015)... , April 17, 2015  Over the next five years, ... to grow, with ArcView predicting that 14 more states will ... marijuana. The U.S. market for legal cannabis grew 74 percent ... 2013. Analysts project the market could grow more than fourfold ... states soften their stance on marijuana. Cannabiz Mobile ...
Breaking Medicine Technology:Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Healthcare Conference on Friday, September 17, 2010 at 8:35 a.m. ... the Four Seasons in Boston.  Steve Worland, Ph.D., President and ... Anadys and its clinical development programs. Dr. Worland ...
... SYK ) announced that it will host a ... Eastern Time, to discuss the Company,s operating results for the ... Operating results for the quarter ended September 30, 2010 will ... participate in the conference call dial 866-270-6057(domestic) or ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Stryker to Host Conference Call on October 19, 2010 2
(Date:4/19/2015)... Autocarinsurancecheap.com has released a new blog post ... protection for vulnerable family members. , Accidental death ... or is disabled in an accident. The policy will ... an auto insurance plan. However, AD&D insurance can also ... life insurance policy. The newly blog post presents the ...
(Date:4/19/2015)... Carinsurancesavings.biz has released a new blog post explaining ... who have diabetes. , Clients who have diabetes ... newly released blog post explains how diabetes influences auto ... low cost coverage. , It is now possible ... single website. Clients can visit http://carinsurancesavings.biz for ...
(Date:4/19/2015)... 19, 2015 McCann Investigations, a Texas-based ... the publication of white paper Married, but Dating: ... As online media provides a unique environment of privacy, ... specifically targeting adulterous spouses has emerged. Social platforms ... as easy as shopping online. Dating sites and ...
(Date:4/18/2015)... York, NY (PRWEB) April 19, 2015 ... experienced strong growth during the past five years. The ... individuals who are unable to fully care for themselves, ... the growing need for dementia care for seniors with ... to rise at an annualized rate of 4.1% to ...
(Date:4/18/2015)... "I recognized the need for a better ... an inventor from Cincinnati, Ohio. "This need inspired me ... the Slyde Door to offer an alternative to the ... provides convenient storage space for an evacuation stretcher. The ... patients. , This offers added peace of mind ...
Breaking Medicine News(10 mins):Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Finding Low Cost Auto Insurance for Diabetic Drivers! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... 10 Mark Ganz, President and Chief,Executive Officer of ... of,thought leaders and health policy experts convened by The ... reframe and broaden the,national dialogue on health care reform ... The Aspen Health Stewardship Project will expand the health ...
... Women under the age of forty with breast cancer who ... as adjuvant chemotherapy, may not be benefiting from these drugs. ... levels of hormones such as estrogen, according to research published ... cancer at a young age is very worrying in terms ...
... urges Congress to,pass legislation this year to ... WASHINGTON, Oct. 10 The Health IT ... and former,Representative Nancy Johnson, today applauded Representatives ... that will bring health,information technology to all ...
... Oct. 10 XShares Advisors LLC, on behalf ... 12-month supporting,relationship with the Parkinson,s Disease Foundation (PDF), ... public advocacy. XShares, platinum level support of ... and Clinical Advances in Quality of Life,and exclusive ...
... an investment,company with a family of 20 fund portfolios, ... of its 19 currently NYSE-listed,HealthShares exchange-traded funds (ETFs) to ... requirement to transfer of all ETFs to the,NYSE Arca ... prior to,October 31, 2007. The transfer is expected to ...
... SpectraScience, Inc. (OTC,Bulletin Board: SCIE) announced today ... of the Company,s quality system from the Notified,Body ... reference to,Annex II.3 of the European directive 93/42/EEC. ... issued. Jim Hitchin the Company,s CEO said, ...
Cached Medicine News:Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Cancer conflict with chemotherapy treatment 2Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 2Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 3Health News:XShares Supports Parkinson's Disease Foundation 50th Anniversary Educational Symposium 4Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 2Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 3Health News:XShares Group LLC to Begin the Transfer of HealthShares(TM) NYSE-Listed ETFs to NYSE Arca 4Health News:SpectraScience Receives Final European Certification 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: